November 19, 2020 David Fox
Featured

Potential for FDA Fast-Track Approval Designation & Imminent Product Launch

Pure Pharmaceutical Cannabidiol, Cardiol Therapeutics Inc.’s (TSX:CRDL)(OTCQX:CRTPF) Medicine has a Significant First-to-Market Advantage When it comes to pharmaceuticals, timing is EVERYTHING. The 2010s were defined as a decade of drug breakthroughs. Over the last 10 years, the Nasdaq Biotech Index is up 355% from 843 to 3,000 (this is even after the coronavirus crash!). Among … Continue reading “Potential for FDA Fast-Track Approval Designation & Imminent Product Launch”